Modulation of immunity by the secreted phospholipase A2 family.

Autor: Murakami, Makoto^1,2 (AUTHOR) makmurak@m.u‐tokyo.ac.jp, Sato, Hiroyasu¹ (AUTHOR), Taketomi, Yoshitaka¹ (AUTHOR)

Publikováno v: Immunological Reviews. Aug2023, Vol. 317 Issue 1, p42-70. 29p.

Modulation of immunity by the secreted phospholipase A 2 family.

Autor: Murakami M; Laboratory of Microenvironmental and Metabolic Health Science, Center for Disease Biology and Integrative Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.; AMED-CREST, Japan Agency for Medical Research and Development, Tokyo, Japan., Sato H; Laboratory of Microenvironmental and Metabolic Health Science, Center for Disease Biology and Integrative Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan., Taketomi Y; Laboratory of Microenvironmental and Metabolic Health Science, Center for Disease Biology and Integrative Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

Publikováno v: Immunological reviews [Immunol Rev] 2023 Aug; Vol. 317 (1), pp. 42-70. Date of Electronic Publication: 2023 Apr 10.

Pharmacology of LY315920/S-5920, [[3-(aminooxoacetyl)-2-ethyl-1- (phenylmethyl)-1H-indol-4-yl]oxy] acetate, a potent and selective secretory phospholipase A2 inhibitor: A new class of anti-inflammatory drugs, SPI.

Autor: Snyder DW; Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana 46285, USA., Bach NJ, Dillard RD, Draheim SE, Carlson DG, Fox N, Roehm NW, Armstrong CT, Chang CH, Hartley LW, Johnson LM, Roman CR, Smith AC, Song M, Fleisch JH

Publikováno v: The Journal of pharmacology and experimental therapeutics [J Pharmacol Exp Ther] 1999 Mar; Vol. 288 (3), pp. 1117-24.

Indole inhibitors of human nonpancreatic secretory phospholipase A2. 2. Indole-3-acetamides with additional functionality.

Autor: Dillard RD; Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana 46285, USA., Bach NJ, Draheim SE, Berry DR, Carlson DG, Chirgadze NY, Clawson DK, Hartley LW, Johnson LM, Jones ND, McKinney ER, Mihelich ED, Olkowski JL, Schevitz RW, Smith AC, Snyder DW, Sommers CD, Wery JP

Publikováno v: Journal of medicinal chemistry [J Med Chem] 1996 Dec 20; Vol. 39 (26), pp. 5137-58.

Transgenic model for the discovery of novel human secretory non-pancreatic phospholipase A2 inhibitors.

Autor: Fox N; Department of Cardiovascular Research, Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, IN 46285, USA., Song M, Schrementi J, Sharp JD, White DL, Snyder DW, Hartley LW, Carlson DG, Bach NJ, Dillard RD, Draheim SE, Bobbitt JL, Fisher L, Mihelich ED

Publikováno v: European journal of pharmacology [Eur J Pharmacol] 1996 Jul 18; Vol. 308 (2), pp. 195-203.